Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-associated antigen 791Tgp72 is a cell surface glycoprotein overexpressed in various human tumors, particularly colorectal cancers. Also known as CD55 or Decay-Accelerating Factor (DAF), it regulates the complement system and contributes to immune evasion by tumor cells. It is a target for cancer immunotherapy and diagnostic applications.
Induction of cellular immune responses against tumors expressing 791Tgp72/CD55
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor-associated antigen 791Tgp72.